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Pressure-induced constriction (also known as the “myogenic response”) is an important
mechano-dependent response in certain blood vessels. The response is mediated
by vascular smooth muscle cells (VSMCs) and characterized by a pressure-induced
vasoconstriction in small arteries and arterioles in the cerebral, mesenteric, cardiac, and
renal beds. The myogenic response has two important roles; it is a mechanism of blood
flow autoregulation and provides protection against systemic blood pressure-induced
damage to delicate microvessels. However, the molecular mechanism(s) underlying
initiation of myogenic response is unclear. Degenerin proteins have a strong evolutionary
link to mechanotransduction in the nematode. Our laboratory has addressed the
hypothesis that these proteins may also act as mechanosensors in certain mammalian
tissues such as VSMCs and arterial baroreceptor neurons. This article discusses the
importance of a specific degenerin protein, β Epithelial Na+ Channel (βENaC) in
pressure-induced vasoconstriction in renal vessels and arterial baroreflex function as
determined in a mouse model of reduced βENaC (βENaC m/m). We propose that loss
of baroreflex sensitivity (due to loss of baroreceptor βENaC) increases blood pressure
variability, increasing the likelihood and magnitude of upward swings in systemic pressure.
Furthermore, loss of the myogenic constrictor response (due to loss of VSMC βENaC) will
permit those pressure swings to be transmitted to the microvasculature in βENaC m/m
mice, thus increasing the susceptibility to renal injury and hypertension.
Keywords: baroreflex, degenerin, epithelial Na+ channel, hypertension, mechanotransduction, myogenic
constriction, renal blood flow, renal injury
INTRODUCTION
Mechanotransduction in vascular tissues is a topic of physiologic
and pathophysiologic relevance. Chronic and transient mechani-
cal forces contribute to development of atherosclerosis, angiogen-
esis, endothelial function, ischemia-reperfusion injury, myogenic
constriction, and hypertension (Hill et al., 2006; Shin et al., 2008;
Heo et al., 2011; Johnson et al., 2011). However, the molecu-
lar mechanisms underlying transduction of mechanical forces,
particularly the transduction of transient mechanical forces into
rapid changes in cellular function, remain unclear. Our laboratory
has been investigating the molecular mechanism(s) underlying
initiation of the myogenic response in renal vasculature.
WHAT IS THE MYOGENIC RESPONSE ANDWHY IS IT
IMPORTANT?
THE MYOGENIC RESPONSE
The myogenic response was initially described over 100 years ago
(Bayliss, 1902). It is generally accepted that themyogenic response
is initiated by pressure-induced vessel wall stretch (Davis andHill,
1999; Hill et al., 2001). Expansion of the vessel wall stretches vas-
cular smooth muscle cells (VSMCs) circumferentially arranged
around the vessel. In turn, VSMC stretch initiates a depolarization
event, which is thought to activate voltage gated Ca2+ channels
(VGCC). Ca2+ channel activation stimulates Ca2+ influx and
triggers vasoconstriction (Figure 1A) (Davis and Hill, 1999; Hill
et al., 2001).
PHYSIOLOGICAL SIGNIFICANCE OF MYOGENIC CONSTRICTION:
REGULATION OF RENAL BLOOD FLOW AND PROTECTION FROM INJURY
The myogenic response is important because it participates in
two processes. First, it is a mechanism of blood flow autoregu-
lation, in which blood flow is tightly controlled despite changes
in systemic perfusion pressure (Navar, 1978; Navar et al., 1982).
Myogenic constriction is fast acting and adjusts vascular resis-
tance to a change in perfusion pressure within 5–10 s. The other
mechanism, tubuloglomerular feedback (TGF), is slower adjust-
ing vascular resistance within 6–25 s (Cupples et al., 1996; Just
and Arendshorst, 2003; Cupples and Braam, 2007; Just and
Arendshorst, 2007). The fast nature of the myogenic response
has led several investigators to suggest the other purpose of the
myogenic response is to prevent the transmission of high sys-
temic pressures to the fragile glomerular microvasculature, thus
protecting microvasculature from pressure-related injury asso-
ciated with hypertension, diabetes, and end stage renal disease
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FIGURE 1 | Initiation of the myogenic response. (A) The sequence of events leading myogenic constriction. (B) Hypothetical role of degenerin proteins as a
mechanotransducer in VSMCs.
(Loutzenhiser et al., 2002; Marsh et al., 2005). While much is
understood about signaling mechanisms underlying VSMC con-
traction, our understanding of the signaling mechanisms that
transduce changes in intraluminal pressure into a cellular signal-
ing event, i.e., the events that initiate myogenic constriction, is
limited.
Several signaling mechanisms are essential to the trans-
duction of mechanical stimuli including, but not limited
to, transient receptor potential (TRP) channels, integrins,
membrane-associated lipids, VGCC, and potassium channels
(Davis and Hill, 1999; Davis et al., 2001; Hill et al., 2001, 2006;
Montell, 2005). Excellent reviews on these topics can be found
elsewhere (Davis andHill, 1999; Davis et al., 2001; Hill et al., 2001,
2006; Montell, 2005). However, in addition to these mechanisms,
we hypothesize degenerin proteins are also essential to VSMC
mechanotransduction by acting as components of a large, het-
eromultimeric mechanosensor that transduces stretch into a cel-
lular event. We do not hypothesize that degenerin proteins form
“the vascular mechanosensor,” but rather they are components
of a large mechanosensing complex that includes, or is closely
associated with, other signaling mechanisms such as integrins,
TRP channels, VGCC, andmembrane associated lipids. Although
studies addressing this latter point have not been published, this
review addresses numerous studies from our laboratory support-
ing an essential role for at least one degenerin protein in VSMC
mechanotransduction.
COULD DEGENERIN PROTEINS PARTICIPATE IN
MECHANOTRANSDUCTION IN VSMCs?
DEGENERIN PROTEINS
Degenerin proteins are a large family of proteins expressed in a
diverse species, including the nematode, Caenorhabditis elegans
(C. elegans), Drosophila, and mammals, with strong evolution-
ary ties to mechanotransduction in neuronal and muscle tissues
(Kizer et al., 1997; Tavernarakis and Driscoll, 1997, 2001; Benos
and Stanton, 1999; Mano and Driscoll, 1999; Trujillo et al., 1999;
Kellenberger and Schild, 2002; Goodman and Schwarz, 2003;
Syntichaki and Tavernarakis, 2004; Arnadottir and Chalfie, 2010).
Members of this family share a common structure: intracellu-
lar N- and C-termini and a large extracellular domain separated
by two membrane-spanning domains. Many of the degenerin
proteins form homo- and heteromultimeric, non-voltage gated,
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Na+/cation channels (Benos et al., 1995; Tavernarakis and
Driscoll, 2001; Kellenberger and Schild, 2002; Goodman and
Schwarz, 2003).
In mammals, three subfamilies of degenerin proteins have
been identified: the Epithelial Na+ Channel (ENaC), Acid Sensing
Ion Channel (ASIC), and Brain Liver Intestine Na+ Channel
(BLINaC) proteins. ENaC proteins are known for their role in
Na+ and water transport in the kidney, lung, and colon epithe-
lia. In these tissues, α, β, and γENaC proteins form a non-voltage
gated, Na+ selective ion channel. The αβγENaC channel is inhib-
ited by low doses (submicromolar to low micromolar range) of
the diuretic amiloride and its analog benzamil. ENaC proteins
have also been found at several important sites of mechan-
otransduction including light touch receptors in skin (Pacinian
Corpuscles, Meissner Corpuscles, Merkel Cells, free nerve end-
ings), osteoclasts, keratinocytes, arterial baroreceptor neurons,
endothelial cells, and VSMCs (Kizer et al., 1997; Drummond
et al., 2000, 2001, 2004; Mauro et al., 2002; Wang et al., 2009).
Furthermore, αβγENaC channels are gated by shear stress (Satlin
et al., 2001; Carattino et al., 2004). Because of their close evolu-
tionary relationship to the C. elegans degenerins, localization in
mechanosensitive tissues, and ability to form ion channels that
may be gated by mechanical forces, ENaC proteins have been
considered as likely components of mechanosensitive ion channel
complexes in vertebrate tissue.
THE DEGENERINMECHANOSENSOR: A POTENTIAL MODEL
FOR A MAMMALIAN MECHANOSENSOR
A model of a mammalian mechanosensor has not been estab-
lished. However, numerous genetic studies have led to the
development of an “all-purpose” model of mechanotransduc-
ers in C. elegans neuronal and muscle tissue (Syntichaki and
Tavernarakis, 2004). The model consists of three components:
(1) an ion-conducting pore, (2) extracellular matrix and proteins
that may link the pore to the matrix, and (3) cytoskeleton and
proteins that may link the pore to the cytoskeleton. In this model,
degenerin proteins form the ion channel pore. The application of
a mechanical force is transduced through the extracellular matrix
to gate the channel. Thus, the interaction between the pore form-
ing degenerin proteins and the extracellular matrix is considered
critical to channel gating. The cytoskeleton may also participate in
transduction of the applied force and along with other extracellu-
lar proteins, may also stabilize the pore forming proteins at the cell
surface. We hypothesize that a similar model applies to mechan-
otransduction in mammalian tissues. Therefore, we are using the
C. elegans model as a platform to develop a model of a mam-
malian mechanosensor (Figure 1B). We further hypothesize that
mammalian degenerin proteins form the ion-conducting pore.
Activation of the mechanosensor leads to influx of Na+ and/or
Ca2+, which leads to membrane depolarization and subsequent
activation of VGCC.
THE EARLY YEARS: ESTABLISHING A ROLE FOR DEGENERIN
PROTEINS IN RENAL MYOGENIC CONSTRICTION
ENaC PROTEINS IN RENAL VSMCs
To consider ENaC proteins as mechanosensors mediating
pressure-induced constriction in blood vessels, ENaC proteins
must be expressed in VSMCs and located at the site of
mechanotransduction, near the cell surface. Therefore, early
studies focused on the expression and localization of ENaC
proteins in VSMCs isolated from myogenically active vascular
beds (Drummond et al., 2004; Jernigan and Drummond, 2005;
Jernigan et al., 2008). As shown in Figure 2, VSMCs enzymatically
dissociated from renal arterial segments express β and γENaC,
but not α, at or near the cell surface membrane (Jernigan and
Drummond, 2005). Since the expression level of the C.elegans
degenerin proteins is low (Lai et al., 1996), we expected a similar
low expression level in VSMCs, and thus extensive optimization
of the immunofluorescence assay was required. The localization
pattern is significant because the cell surface is the site where
the mechanosensor might be predicted to be located. The lack
of αENaC in VSMCs is also an important finding. It has been
suggested that the lack of αENaC would render β and γENaC
unable to form a channel in VSMCs. While αENaC is required for
high conductance and constitutive activity properties of the “clas-
sical” ENaC channel found in epithelial tissue, β and γ–rat ENaC
can form an amiloride-sensitive, Na+ conducting channel in the
absence of αENaC (Bonny et al., 1999). The presence of δENaC, a
subunit that can confer a high level of activity to βγENaC in the
absence of αENaC, has not yet been determined as it is apparently
not present in mouse or rat (Waldmann et al., 1995; Kapoor et al.,
2009; Giraldez et al., 2012). The possibility of another subunit,
such as an ASIC protein or unidentified ENaC, interacting with
β and γENaC to form a channel has not been ruled out.
FIGURE 2 | Localization of βENaC and γENaC in enzymatically
dissociated renal VSMCs. VSMCs were identified by labeling with a
smooth muscle actin (left column). We detected βENaC and γENaC, but not
αENaC, at or near the VSMC surface. The strongest labeling is consistently
observed for βENaC. Scale bar represents 5μm. (Figure includes images
reproduced from American Journal of Physiology, Renal Physiology 289;
F891–F901, 2005, Figure 2).
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ENaC INHIBITION SUPPRESSES RENAL MYOGENIC CONSTRICTION
A second essential criterion to consider ENaC proteins as com-
ponents of a mechanosensor in VSMCs is that physiological
responses to mechanical activation of the myogenic response
can be inhibited following ENaC blockade. Our laboratory has
taken three approaches to determine the importance of ENaC
proteins in renal myogenic constriction in renal interlobar arter-
ies, which include (1) pharmacological inhibition, (2) transient
gene silencing, and (3) genetically modified mice (Jernigan and
Drummond, 2005, 2006; Ge et al., 2012). Our method for
assessment of myogenic constriction is shown in Figures 3A–D.
Renal interlobar artery segments are dissected from surround-
ing tissue and mounted on two pipettes (Figure 3A). Following
an equilibration period to allow the vessel to develop sponta-
neous tone, we expose the vessel to a step-wise (25mm Hg,
5min) increase in perfusion pressure (Figure 3B), done during
incubation with Ca2+ containing and then Ca2+ free extracel-
lular solution. Under Ca2+ containing conditions, vessels will
constrict in response to the increase in pressure. However, under
Ca2+ free conditions, vessels will passively dilate in response to
the increase in pressure (Figure 3C). Myogenic tone is calcu-
lated as the difference in diameter between Ca2+ containing and
Ca2+ free conditions divided by Ca2+ free diameter. A vessel seg-
ment with a myogenic response will exhibit an increase in tone
with an increase in pressure. The pressure-myogenic tone rela-
tionship will be flat in a vessel without a myogenic response
(Figure 3D). If degenerin proteins are important in the transduc-
tion of myogenic constriction, then we expect the relationship
between pressure and myogenic tone to be altered following
degenerin inhibition.
To determine if degenerin proteins in general contributed
to the transduction of the myogenic response, we first used
FIGURE 3 | In vitro assessment of myogenic constriction. (A) Image of an
isolated renal interlobar artery segment tied to inflow and outflow perfusion
pipettes. (B) To assess myogenic responsiveness vessels are exposed to a
step-wise increase in perfusion pressure (25mm Hg step, 5min each) from
25 to 150mm Hg under normal external Ca2+ and Ca2+ free solutions to
determine active response and passive responses, respectively (C). (C) The
steady state diameter is plotted vs. pressure to obtain a pressure-diameter
relationship under active vs. passive conditions. (D) Myogenic tone is
calculated as [(passive diameter – active diameter)/passive diameter] at each
pressure step. A vessel with active myogenic tone will have an increase in
tone with an increase in pressure. A vessel with reduced or absent myogenic
tone will have a flattened relationship between pressure and tone. (E) Effect
of ENaC inhibition with benzamil on myogenic tone in renal interlobar
arteries. (F) Transient gene-silencing of βENaC or γENaC using
dominant-negative constructs of βENaC or γENaC inhibits myogenic tone in
renal interlobar arteries. (G) Transient gene-silencing of βENaC or γENaC
using siRNA inhibits myogenic tone in renal interlobar arteries. (Figure
reproduced from American Journal of Physiology, Renal Physiology 289;
F891-F901, 2005, Figure 4 and American Journal of Physiology, Renal
Physiology 291; F1184–F1191, 2006, Figures 5, 6).
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broad-spectrum degenerin inhibitors amiloride and its ana-
log benzamil (Jernigan and Drummond, 2005). As shown
in Figure 3E, benzamil abolishes myogenic constriction in
renal interlobar arteries in a concentration-dependent manner.
Amiloride, data not shown, elicited a similar inhibition of myo-
genic constriction. An important factor in the interpretation of
these experiments is the selectivity of the ENaC inhibitors. At
submicromolar and low micromolar doses, benzamil is a fairly
selective inhibitor of ENaC. Furthermore, recent studies by Guan
et al. suggest myogenic constriction in rat afferent arterioles is
also sensitive to ENaC inhibition (Guan et al., 2009). However,
another study by Wang et al., benzamil/amiloride did not inhibit
myogenic constriction in renal arterioles (Wang et al., 2008).
While pharmacological inhibition is a great tool for screening
for ENaC/ASIC involvement, specific subunit involvement can-
not be determined. To determine the importance of the two
ENaC proteins detected in renal VSMCs (βENaC and γENaC),
we used siRNA and dominant-negative constructs to specifically
silence β or γENaC expression in isolated mouse renal interlo-
bar artery segments (Figures 3F,G) (Jernigan and Drummond,
2006). With these approaches, specific ENaC subunit expression
was inhibited 50–70% in renal VSMCs. Following ENaC silenc-
ing, pressure-induced constrictor responses were inhibited by
40–80%, without altering the ability of the vessel to constrict to
phenylephrine, suggesting the loss of vasoconstriction is specific
to pressure rather than a generalized loss in the ability of the vessel
to constrict.
THE βENaC M/MMOUSE: A MODEL TO DETERMINE
THE PHYSIOLOGICAL IMPORTANCE OF DEGENERIN
MEDIATED MYOGENIC CONSTRICTION
Our early studies suggested an important role for certain
degenerin proteins in myogenic constriction, however, under-
standing the consequences of long term loss of degenerin medi-
ated myogenic constriction on cardiovascular health required a
genetic model. For these studies, we focused on βENaC because
our previous findings suggested βENaC may play a more impor-
tant role.
THE βENaC M/MMODEL
Since βENaC null mice die shortly after birth (McDonald et al.,
1999), we selected an alternative model with reduced levels
of βENaC, βENaC m/m model developed by Bernard Rossier
and Edith Hummler at the University of Lausanne, Switzerland
(Pradervand et al., 1999). The βENaC m/m model was gen-
erated using standard gene targeting approaches in the course
of generating a model of Liddle’s syndrome (increased βENaC)
by inserting a premature stop codon in the C-terminus cod-
ing region. However, the presence of the neomycin selection
marker disrupts the βENaC gene locus resulting in reduced βENaC
expression. Thus, a mouse model that under-, rather than over-
expresses, βENaC was generated. Mice homozygous for the muta-
tion (m/m) express very low levels of βENaC transcripts and/or
protein in the lung, kidney, and VSMCs, including small cere-
bral arteries and renal afferent arterioles (Pradervand et al., 1999;
VanLandingham et al., 2009; Grifoni et al., 2010; Drummond
et al., 2011; Ge et al., 2012). Co-localization of βENaC with
smooth muscle α-actin in afferent arteriolar VSMCs is shown in
Figure 4A. Note the significantly reduced labeling for βENaC in
renal afferent arteriolar VSMCs from βENaCm/mmice (Ge et al.,
2012).
MYOGENIC CONSTRICTION IN AFFERENT ARTERIOLES IS
ATTENUATED IN βENaC M/M MICE
To determine the importance of βENaC to afferent arteriolar
myogenic constriction, we examined pressure-induced constric-
tion using the attached afferent arteriole-glomerulus preparation
(Figure 4B) (Ge et al., 2012). In this preparation, a single afferent
arteriole attached to a glomerulus is dissected from the kidney
and perfused at 60, then 120mm Hg. The afferent arterioles
from the βENaC +/+ mice develop significant myogenic tone
in response to the step increase in pressure. However, afferent
arterioles from βENaC m/m mice develop significantly less tone,
suggesting βENaC mediates transduction of pressure-induced
FIGURE 4 | Localization of βENaC and contribution to myogenic
constriction in renal afferent arteriole. (A) Localization of SM α-actin (left)
and βENaC (right) in a cross-sectional image of a renal arteriole from a
βENaC +/+ (top) and m/m (bottom) mouse. In the merged image, an “L”
identifies the arteriolar lumen and an asterisk (∗) identifies the VSMC cell
bodies. (B) Image of an isolated afferent arteriole with attached glomerulus
preparation. (C) Steady state vasoconstrictor responses to an increase in
pressure in afferent arterioles in βENaC +/+ and m/m animals (n = 6).
Vasoconstrictor responses to adrenergic agonist norepinephrine (NE) were
similar (not shown). (Figure reproduced from American Journal of
Physiology, Renal Physiology 302; F1486–F1493, 2012, Figures 1, 2).
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constriction in afferent arterioles (Figure 4C). This later finding
is very significant because the afferent arteriole is the primary
site of development of vascular resistance in the kidney, and thus
likely contributes to control of whole kidney vascular resistance
and blood flow regulation.
MYOGENIC REGULATION OF RENAL BLOOD FLOW IS
ATTENUATED IN βENaC M/MMICE
To begin to address the potential physiologic and pathophysio-
logic importance of βENaCmediated renal myogenic constriction
in the regulation of whole kidney renal blood flow (RBF), we
again turned to the βENaC m/m mouse model. In two recent
studies, we utilized the temporal separation between the onset
of the myogenic mechanism (0–5 s) and the TGF mechanism
(6–25 s) to determine the contribution of βENaC to myogenic
regulation of RBF (Grifoni et al., 2010; Ge et al., 2012) (Figure 5).
In these studies, mice were instrumented with a carotid arte-
rial catheter for blood pressure measurement and a renal flow
probe for measurement of whole kidney blood flow (Figure 5A).
A step increase in blood pressure was achieved with an occlu-
sion of the lower abdominal aorta, just below the renal artery
(Figures 5A,B). As shown in Figures 5C,D, RBF increases and
RVR decreases immediately following the step increase in pres-
sure. Within 5–10 s, RBF begins to return to control levels in+/+
animals due to myogenically mediated vasoconstriction (increase
in RVR). In contrast, RBF remains elevated and RVR remains
reduced in the m/m mice, suggesting a loss of myogenic regu-
lation. To assess the integrity of renal myogenic regulation, we
quantified the speed of the myogenic mechanism by the deter-
mining the rate of change in whole kidney vascular resistance
during the first 5 s following a step increase in renal perfusion
pressure [Slope RVR0–5 S, Figure 5E (Ge et al., 2012)]. We found
myogenic speed was suppressed nearly 80%, findings that paral-
lel our in vitro findings (loss of myogenic constriction in afferent
arterioles) in βENaC m/m mice. Thus, the loss of βENaC medi-
ated myogenic constriction prevents the rapid correction of RBF
that normally occurs following a fluctuation in systemic blood
pressure, thus leading to inappropriate regulation of RBF.
SIGNS OF RENAL INFLAMMATION ANDMILD INJURY IN THE
βENaC M/M MOUSE
Inappropriate regulation of RBF is linked to renal injury in
hypertension and diabetes (Bidani et al., 2003, 2007). Normally,
swings in systemic pressure are prevented from reaching the
tiny, delicate renal microvasculature because of autoregula-
tory mechanisms; when systemic pressure rises, autoregulatory
mechanisms are activated leading to vasoconstriction, which
prevents transmission of higher systemic pressures to delicate
microvessels (Bidani et al., 2003, 2007; Griffin et al., 2004;
Loutzenhiser et al., 2006). The myogenic response responds
rapidly to changes in perfusion pressure and is thus considered
the principal mechanism to prevent transmission of pressure
swings to the microvasculature. Since the βENaC m/m mice
have reduced myogenic capacity, we considered the possibility
that βENaC m/m mice might have signs of renal injury and
possibly, elevated blood pressure. To address these issues, we
examined kidneys for indicators of renal injury (Drummond
et al., 2011). We found that compared to +/+ littermates,
βENaC m/m mice have signs of inflammation and mild renal
injury characterized by increased levels of renal inflammatory
cytokines (TNFα, IL1β, IL6), inflammatory cells (macrophages,
lymphocytes), growth factors linked to pressure-dependent injury
(TGFβ), and mild expansion of extracellular matrix (Drummond
et al., 2011). We also found that βENaC m/m mice have a
mean blood pressure that is ∼15mm Hg higher than wild-
type littermates (Figures 6A,B), as determined by telemetry
(Drummond et al., 2011). These findings demonstrate a link
between altered βENaC mediated myogenic function, renal
injury, and hypertension.
ISN’T THE βENaC M/M MOUSE SUPPOSED TO BE
HYPOTENSIVE?
Because the βENaC m/m mouse was generated using homolo-
gous recombination, reduced levels of βENaC would be expected
in all tissues, including renal tubular cells. Loss of tubular ENaC
related salt and water transport would be expected to be associ-
ated with reduced or normal blood pressure (with compensatory
up-regulation of sodium retaining hormones). Thus, at first con-
sideration, our finding that blood pressure is elevated in the
βENaCm/m may seem counter-intuitive. However, when the ele-
vated blood pressure data is taken in context with loss of myogenic
autoregulation and presence of renal inflammation in the βENaC
m/m, renal injury related increases in blood pressure becomes a
plausible explanation.
CONTRIBUTING FACTOR TO RENAL INJURY: ARTERIAL
BARORECEPTORDYSFUNCTION IN βENaC M/MMICE?
ENaC proteins have also been considered potential mechan-
otransducers in arterial baroreceptors, which are the sensory
portion of a neural reflex that helps to buffer fluctuations in arte-
rial blood pressure that occur with normal activity (Cowley et al.,
1973; Drummond et al., 2001). When blood pressure suddenly
changes, specialized nerve endings located in the aortic arch and
carotid sinuses senses changes in vascular stretch and relay signals
to the brain stem to inversely control sympathetic and parasym-
pathetic nerve activity to periphery to adjust vascular resistance,
heart rate and cardiac contractility to return blood pressure to
control. For example, a sudden increase in blood pressure will
activate peripheral arterial baroreceptors, which will send sig-
nals to the brain stem. In response, sympathetic outflow will be
suppressed to decrease cardiac contractility, heart rate, and vas-
cular resistance and return blood pressure to control. If βENaC
were a component of an arterial baroreceptor mechanotrans-
ducer, then we would expect that βENaC m/m mice might have
altered baroreflex sensitivity. During collection of blood pressure
data in themice, we noticed an increased variability in blood pres-
sure values among measurement intervals in βENaC m/m mice
(Drummond et al., 2011), suggesting a labile blood pressure con-
sistent with a loss of baroreceptor function. To further address
the possibility that arterial baroreceptor function may be altered
in βENaC m/m mice, we used “sequence analysis” to determine
if heart rate responses to spontaneous fluctuations in systemic
blood pressure were altered in βENaC m/m mice (Figures 6A,B).
For these studies, we used the approach and criteria used by
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FIGURE 5 | βENaC mediates myogenic regulation of whole kidney blood
flow and renal vascular resistance. (A) Schematic of animal preparation.
Mice have an arterial carotid catheter for blood pressure measurement and a
renal flow probe for whole kidney blood flow measurement. An occluder tie
placed around the lower abdominal aorta is used to generate the step
increase in pressure. (B) Time course of the regulatory response of mean
arterial pressure (MAP; B), renal blood flow (RBF; C), and renal vascular
resistance (RVR; D), in wild type (+/+, filled symbols, n = 6) and mutant
(m/m, open symbols, n = 7) 10 s before and 10s after the step increase in
pressure. Data are presented as normalized changes in B–D to minimize
variance. Following a similar increase in MAP, the transient increase in RBF
and decrease in RVR are similar between +/+ and m/m mice. Immediately
following the transient drop, RVR begins to increase in the +/+, but remains
low in the m/m. (E) The rate of increase in RVR during the first 5 s following
the drop in RVR (Slope RVR0–5S) is significantly greater in +/+ vs. m/m mice
(p = 0.014). By 20–30 s following the step increase in MAP, RBF in the +/+ is
corrected while RBF remains elevated in m/m animals. By 20–30s
following the step increase in MAP, the change in RVR from baseline is
greater in the +/+ vs. m/m. Data are mean ± SEM. ∗Significantly different
from βENaC +/+ group at the p-value indicated. (Figure reproduced from
American Journal of Physiology, Renal Physiology 302; F1486–F1493, 2012,
Figure 3).
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FIGURE 6 | Blood pressure and arterial baroreflex gain in normal salt
(0.4% Na+) fed animals.Mean arterial pressure (MAP) for 12-h light
(L)–dark (D) cycles for each of 5 days and the average of 5 days are shown in
panels A and B, respectively in wildtype (+/+, n = 8) and homozygous
βENaC mutant mice (m/m, n = 7). (C) Arterial baroreflex gain is significantly
lower in βENaC m/m mice (n = 4) vs. +/+ controls. (D) Mean arterial blood
pressure (MAP) variability during the last 24h of blood pressure recording
was significantly elevated in βENaC m/m mice (same animals as shown in
A and B). (Figure reproduced from American Journal of Physiology, Renal
Physiology 301; F443–F449, 2011, Figures 2, 3). Data are mean ± SEM. BPM
is heart rate in beats per minute. ∗Significantly different from wildtype (+/+)
control animals, p < 0.05.
others (Braga et al., 2008). We found that gain of the barorecep-
tor sequences (up and down) were significantly lower in βENaC
m/m mice (Figure 6C), consistent with reduced baroreflex sen-
sitivity. This is an important finding because altered baroreflex
sensitivity would be expected to increase blood pressure vari-
ability, which would increase the magnitude and/or frequency of
blood pressure swings. To determine if the altered baroreflex sen-
sitivity translated into increased variability in blood pressure, we
quantified the variability in mean arterial pressure (MAP) mea-
surements during the last 24 h of blood pressure recording. As
shown in Figure 6D, MAP was more variable in βENaC m/m
mice. Normally, these blood pressure swings should not pose
a problem, however, if these swings are superimposed on an
background of weakened myogenic constriction, the increased
frequency and/or magnitude of upward swings in blood pressure
translate may into more opportunities for transmission of dam-
aging systemic pressure to the delicate renal microvasculature,
and consequently, increased likelihood for renal injury (Figure 7).
Over the course of a lifetime, those repeated pressure insults
to the microvessels are likely to promote injury. Thus, reduced
baroreflex sensitivity, coupled with reduced myogenic capacity,
likely contributes to the renal injury and increased blood pres-
sure observed in the βENaC m/m model. This hypothesis has
been proposed previously for anothermodel of hypertensive renal
injury (Iliescu, 2007).
FUTURE DIRECTIONS
Degenerin mediated vascular function is a new field, and as such,
there is much that needs to be done to elucidate the impor-
tance of degenerins in vascular function. Pressure-dependent
renal injury is a leading cause of end-stage renal disease with
substantial financial costs (Medicare Care costs exceeded $26 bil-
lion in 2010) (USRDS, 2008, 2010). Understanding the degenerin
mediated protection from injury will lead to development of
approaches to prevent renal injury. Although the loss of renal
pressure-dependent vascular function in βENaC m/m mice does
not lead to severe renal injury and hypertension, it is not clear if
a “second hit,” such as high Na+ diet, elevated angiotensin II, or
added psychological stress would increase the severity of injury.
Furthermore, information learned from the renal circulation may
also apply to other myogenically active circulations, such as the
cardiac and cerebral beds.
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FIGURE 7 | Schematic of working hypothesis: the role of βENaC as
a mechanosensor and its role in cardiovascular pathophysiology.
We hypothesize that βENaC is a critical component of mechanosensors
in renal VSMCs and arterial baroreceptor neurons. Loss in βENaC
function in renal VSMCs leads to a loss in renal myogenic constriction
and a delayed or impaired correction of renal blood flow following
upward swings in blood pressure. Loss in βENaC function in arterial
baroreceptor neurons leads to a loss in baroreflex control of blood
pressure and increased BP lability. Increased BP lability and decreased
myogenic constriction increase the opportunities and magnitude of
systemic pressure transmission to the renal microvessels, which in
turn, increases susceptibility to end-organ injury and hypertension.
Determining the identity of other proteins that form the het-
eromultimeric mechanosensor in VSMCs is also an important
future direction. Based on the C. elegansmodel, the mechanosen-
sor is a large heteromeric complex. The pore, which may be
formed one or more degenerin proteins, is tethered to the
cytoskeleton and extracellular matrix. The identity of the other
pore forming subunit(s) and the cytoskeleton and extracellu-
lar matrix proteins responsible for tethering the pore in VSMCs
have not been identified. Understanding their identity and reg-
ulation by hormonal, inflammatory, and autocrine factors may
provide additional insight into the prevention and treatment of
renal injury. It is very likely that VSMC ENaC protein expression
and/or function may be altered in hypertension because many of
the “usual suspects” implicated in hypertension (i.e., endothelin,
aldosterone, angiotensin II, inflammatory cytokines, reactive oxy-
gen species, and nitric oxide, dietary salt) regulate tubular ENaC
and neuronal ASIC channel expression (Gilmore et al., 2001;
Mamet et al., 2002, 2003; Beutler et al., 2003; Amasheh et al., 2004;
Barmeyer et al., 2004; Drummond et al., 2006; Helms et al., 2008;
Jernigan et al., 2008, 2009; Pavlov et al., 2010; Chung et al., 2011).
SUMMARY
Our laboratory has considered degenerin proteins, specifically
βENaC and γENaC, as components of a mechanosensor in
VSMCs because of their strong evolutionary link to mechan-
otransduction in C. elegans. Multiple lines of in vitro and
in vivo evidence support this hypothesis. The evidence includes
(1) appropriate protein localization, (2) disruption of myogenic
constriction in isolated vessels using pharmacological, transient
gene silencing, and genetically modified animals, and (3) disrup-
tion of myogenically mediated whole organ blood flow in vivo.
Furthermore, the potential importance of degenerin mediated
vascular function on cardiovascular health is becoming clear; loss
of vascular degenerin function may inhibit the protective renal
myogenic mechanism and increase blood pressure variability,
thereby increasing susceptibility to pressure related renal injury
and hypertension.
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